Roche’s Tecentriq cocktail scores trial success in melanoma
The study met its primary aim of showing progression-free survival in patients with previously untreated BRAF V600…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.